Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1995
09/12/1995US5449751 Cardiodilatin fragment, process for preparing same and use thereof
09/12/1995US5449750 Cyclic peptide enzyme inhibitors
09/12/1995US5449720 Amplification of the VB12 uptake system using polymers
09/12/1995US5449685 Method and composition for treating HIV-type 1 infections
09/12/1995US5449671 Use of TGF-β3, to prevent or retard fistula closure following glaucoma filtration surgery
09/12/1995US5449669 Peptide desensitizers to tropomyosin; side effect reduction
09/12/1995US5449662 Atrial natriuretic peptide clearance inhibitors which resist degradation
09/12/1995US5449661 Angiotensin converting enzyme inhibitor and method for preparing same
09/12/1995US5449616 Nucleic acid encoding dystrophin-associated protein
09/12/1995US5449608 Detection
09/12/1995US5449522 Antitumor
09/12/1995US5449515 Synergistic amount of lymphokine interleukin-4
09/12/1995US5449355 Retrograde tissue splitter and method
09/12/1995CA2144218A1 Lipases immobilized in sol-gel processed hydrophobic materials
09/12/1995CA1336967C Chemically modified protein and production thereof
09/12/1995CA1336954C Treatment of autoimmune diseases by oral administration of autoantigens
09/08/1995WO1995023867A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
09/08/1995WO1995023866A1 Vector for liver-specific gene therapy
09/08/1995WO1995023865A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
09/08/1995WO1995023862A1 Animals with targeted gene disruption
09/08/1995WO1995023861A1 HUMAN MEGAKARYOCYTOPOIETIN AND ISOLATION THEREOF, cDNA CLONING, AND PREPARATION OF THE RECOMBINANT PROTEIN
09/08/1995WO1995023860A2 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR
09/08/1995WO1995023858A1 A novel voltage-gated potassium channel gene
09/08/1995WO1995023857A1 Yeast strains and modified albumins
09/08/1995WO1995023856A1 Chimeric complement inhibitor proteins
09/08/1995WO1995023855A2 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995WO1995023854A1 IMPROVED DNase LIQUID SOLUTIONS
09/08/1995WO1995023846A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins
09/08/1995WO1995023813A1 In vitro antibody affinity maturation using alanine scanning mutagenesis
09/08/1995WO1995023812A1 Antibiotic stalobacins
09/08/1995WO1995023811A1 Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex
09/08/1995WO1995023810A1 Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds
09/08/1995WO1995023809A1 Antithrombotic agents
09/08/1995WO1995023614A1 Enzymatic debridement compositions and methods
09/08/1995WO1995023613A1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION
09/08/1995WO1995023611A1 Products comprising substrates capable of enzymatic cross-linking
09/08/1995WO1995023610A1 Pharmaceutical composition containing thymoctonan and azt
09/08/1995WO1995023609A1 Antithrombotic agents
09/08/1995WO1995023608A1 Antithrombotic agents
09/08/1995WO1995023599A1 Hla-dm is involved in antigen presentation to t lymphocytes
09/08/1995WO1995023580A1 Preventive and remedy for secondary depilation
09/08/1995WO1995023513A1 Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum
09/08/1995WO1995023512A1 Terminal complement inhibitor fusion genes and proteins
09/08/1995WO1995022609A3 Human glutamate receptor proteins
09/08/1995WO1995021927A3 Targeting gene therapy
09/08/1995WO1995021916A3 Pp32: a newly identified cd45-associated protein
09/08/1995WO1995019429A3 Method and reagent for inhibiting hepatitis c virus replication
09/08/1995CA2184707A1 Animals with targeted gene disruption
09/08/1995CA2184580A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995CA2184356A1 Terminal complement inhibitor fusion genes and proteins
09/08/1995CA2184355A1 Chimeric complement inhibitor proteins
09/08/1995CA2184354A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins
09/08/1995CA2184188A1 Antithrombotic agents
09/08/1995CA2184113A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
09/08/1995CA2184058A1 Kunitz domain inhibitor proteins derived from alzheimer's amyloid .beta.-protein precursor inhibitor
09/08/1995CA2183951A1 Antibiotic stalobacins
09/08/1995CA2183665A1 Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum
09/08/1995CA2183643A1 Products comprising substrates capable of enzymatic cross-linking
09/08/1995CA2183550A1 In vitro antibody affinity maturation using alanine scanning mutagenesis
09/08/1995CA2183464A1 Antithrombotic agents
09/08/1995CA2182396A1 Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds
09/08/1995CA2181787A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
09/08/1995CA2180141A1 Antithrombotic agents
09/08/1995CA2160248A1 Pharmaceutical composition containing thymoctonan and azt
09/07/1995DE4406885A1 New acyl-(chloro-benzyl-oxo-tetra:hydro)-quinolinyl-aminoacid derivs.
09/07/1995DE4406884A1 New amino acid tetra:hydro-quinolone-amide derivs.
09/06/1995EP0670369A2 A novel peptide related to human programmed cell death and DNA encoding it
09/06/1995EP0670366A1 Proteic extract from Cucumis melo with antioxidant activity and process of preparation, cosmetic or pharmaceutic composition or food composition containing such extract
09/06/1995EP0670332A2 Protein complexes having factor VIII:C activity and production thereof
09/06/1995EP0670331A1 Process to reactivate purified membrane proteins by freezing
09/06/1995EP0670330A1 Long-chain alkylamides of aminoacids and peptides with antiproliferative and antiinflammatory properties
09/06/1995EP0670310A1 Bisulfite adducts of arginine aldehydes useful as thrombin inhibitors and as anticoagulants
09/06/1995EP0670166A2 Formulations for orally administered pharmaceutical agents
09/06/1995EP0670165A2 Use of seminal ribonuclease as antimetastatic compound
09/06/1995EP0670163A1 Use of pentoxifylline for the manufacture of a medicament for the treatment of fibrosing or granulomatosing lung diseases
09/06/1995EP0669988A1 Angiogenesis inhibitory antibodies
09/06/1995EP0669987A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
09/06/1995EP0669983A1 Allergenic proteins and peptides from japanese cedar pollen
09/06/1995EP0669982A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
09/06/1995EP0669981A1 Interferon tau compositions and methods of use
09/06/1995EP0669979A1 C-c ckr-1, c-c chemokine receptor
09/06/1995EP0669978A1 Flk-1 is a receptor for vascular endothelial growth factor
09/06/1995EP0669977A1 Transformed endothelial cells
09/06/1995EP0669973A1 Biological factors and neural stem cells
09/06/1995EP0669941A1 Method of reducing multidrug resistance in cells and tissues
09/06/1995EP0669940A1 Specifically crosslinked hemoglobin with free functionality
09/06/1995EP0669939A1 Somatotropin modifications
09/06/1995EP0669938A1 PEPTIDE DERIVATIVES OF $g(a)-MSH AND THEIR APPLICATION
09/06/1995EP0669937A1 Peptide inhibitors of fibronectin and related collagen-binding proteins
09/06/1995EP0669936A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
09/06/1995EP0669934A1 Process for manufacturing crystals of growth hormone and crystals thereby obtained
09/06/1995EP0669930A1 Cellular genes encoding retinoblastoma-associated proteins
09/06/1995EP0669929A1 Novel cytokine designated elk ligand
09/06/1995EP0669925A1 Aids therapeutics based on hiv ma peptides
09/06/1995EP0669912A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
09/06/1995EP0669835A1 Dietary hypocholesterolaemic compositions comprising soya proteins and sitosterols
09/06/1995EP0669834A1 Use of topically applied factor xiii for inhibiting hemorrhage
09/06/1995EP0669833A1 USES OF TGF-$g(b) RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT
09/06/1995EP0669831A1 Treatment of protozoal infection with bacitracin
09/06/1995EP0669830A1 Substituted dipeptide analogs promote release of growth hormone
1 ... 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 ... 3163